Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis

byKing's College LondonGraphical Abstract. Credit:Brain Communications(2024). DOI: 10.1093/braincomms/fcae291Reduced brain activity responding to unpredicted visual changes is a

Updated on: October 16,2024

Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis

byKing's College LondonGraphical Abstract. Credit:Brain Communications(2024). DOI: 10.1093/braincomms/fcae291Reduced brain activity responding to unpredicted visual changes is a

Updated on:October 16,2024

New figures show dementia is leading cause of death in England and Wales

by Alzheimer's Research UKNew figures released by the Office of National Statistics show that for the first time, Alzheimer's disease and other dementias are the leading cause of death fo

Updated on: March 07,2024

New figures show dementia is leading cause of death in England and Wales

by Alzheimer's Research UKNew figures released by the Office of National Statistics show that for the first time, Alzheimer's disease and other dementias are the leading cause of death fo

Updated on:March 07,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on: March 07,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on:March 07,2024

Socioeconomic deprivation linked to higher risk of epilepsy related to traumatic brain injury

by Lori SolomonSocioeconomic deprivation increases the risk for sustaining a traumatic brain injury (TBI), and in some age groups, it may also increase the risk for epilepsy after a TBI, according to

Updated on: July 17,2024

Socioeconomic deprivation linked to higher risk of epilepsy related to traumatic brain injury

by Lori SolomonSocioeconomic deprivation increases the risk for sustaining a traumatic brain injury (TBI), and in some age groups, it may also increase the risk for epilepsy after a TBI, according to

Updated on:July 17,2024

Study finds spinal manipulative therapy benefits patients with tension-type headaches

byUniversity Hospitals Cleveland Medical CenterCredit: Pixabay/CC0 Public DomainA team of researchers led by University Hospitals Connor Whole Health have identified an association between spina

Updated on: December 22,2024

Study finds spinal manipulative therapy benefits patients with tension-type headaches

byUniversity Hospitals Cleveland Medical CenterCredit: Pixabay/CC0 Public DomainA team of researchers led by University Hospitals Connor Whole Health have identified an association between spina

Updated on:December 22,2024

Athletes have significantly better working memory than sedentary people, researchers find

byUniversity of JyväskyläCredit: CC0 Public DomainIn cognitive science, there has recently been increasing attention to the relationship between sports expertise and working memory. However, to

Updated on: November 27,2024

Athletes have significantly better working memory than sedentary people, researchers find

byUniversity of JyväskyläCredit: CC0 Public DomainIn cognitive science, there has recently been increasing attention to the relationship between sports expertise and working memory. However, to

Updated on:November 27,2024

Old drug offers new hope to treat Alzheimer's disease

by Gladstone InstitutesVarious pills. Credit: WikipediaScientists from the Gladstone Institutes have discovered that salsalate, a drug used to treat rheumatoid arthritis, effectively reversed tau

Updated on: February 26,2024

Old drug offers new hope to treat Alzheimer's disease

by Gladstone InstitutesVarious pills. Credit: WikipediaScientists from the Gladstone Institutes have discovered that salsalate, a drug used to treat rheumatoid arthritis, effectively reversed tau

Updated on:February 26,2024

Is dementia on the decline? Research suggests it might be

by Allie Shah, Star Tribune (Minneapolis)Despite fears that the coming silver tsunami will trigger a dementia epidemic, a surprising new study suggests that it may be possible to delay - or even preve

Updated on: February 28,2024

Is dementia on the decline? Research suggests it might be

by Allie Shah, Star Tribune (Minneapolis)Despite fears that the coming silver tsunami will trigger a dementia epidemic, a surprising new study suggests that it may be possible to delay - or even preve

Updated on:February 28,2024

Brain differences seen in young adults at genetic risk of Alzheimer's

by Amy Norton, Healthday ReporterGenetic risk for Alzheimer’s disease is linked to reduced grid-cell-like representations during virtual navigation. Credit: Created by bureaublauwgeel.nl, commissioned

Updated on: February 26,2024

Brain differences seen in young adults at genetic risk of Alzheimer's

by Amy Norton, Healthday ReporterGenetic risk for Alzheimer’s disease is linked to reduced grid-cell-like representations during virtual navigation. Credit: Created by bureaublauwgeel.nl, commissioned

Updated on:February 26,2024

Alzheimer's disease: Five things to know

Credit: Unsplash/CC0 Public DomainAlzheimer's disease, a devastating neuro-degenerative condition that causes dementia, affects more than 30 million people worldwide and remains an illness for whi

Updated on: March 26,2024

Alzheimer's disease: Five things to know

Credit: Unsplash/CC0 Public DomainAlzheimer's disease, a devastating neuro-degenerative condition that causes dementia, affects more than 30 million people worldwide and remains an illness for whi

Updated on:March 26,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on: April 16,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on:April 16,2024

New insights into Niemann-Pick type C: A form of childhood dementia

by Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)Bone marrow-derived macrophages (BMDMs) share key molecular and functional alterations observed in NPC1-deficient microglia. Credit:&

Updated on: December 17,2024

New insights into Niemann-Pick type C: A form of childhood dementia

by Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)Bone marrow-derived macrophages (BMDMs) share key molecular and functional alterations observed in NPC1-deficient microglia. Credit:&

Updated on:December 17,2024